Avecho Biotechnology Limited Stock

Equities

AVE

AU0000047441

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:46 2024-04-30 EDT 5-day change 1st Jan Change
0.004 AUD 0.00% Intraday chart for Avecho Biotechnology Limited -20.00% +14.29%

Financials

Sales 2022 1.13M 734K 1.01M Sales 2023 474K 308K 423K Capitalization 11.09M 7.21M 9.9M
Net income 2022 -2M -1.3M -1.79M Net income 2023 -3M -1.95M -2.68M EV / Sales 2022 23.3 x
Net cash position 2022 1.22M 794K 1.09M Net cash position 2023 5.33M 3.46M 4.76M EV / Sales 2023 12.2 x
P/E ratio 2022
-11.5 x
P/E ratio 2023
-2.31 x
Employees 15
Yield 2022 *
-
Yield 2023
-
Free-Float 65.6%
More Fundamentals * Assessed data
Dynamic Chart
1 week-20.00%
Current month-20.00%
3 months+14.29%
Current year+14.29%
More quotes
1 week
0.00
Extreme 0.0035
0.01
1 month
0.00
Extreme 0.0035
0.01
Current year
0.00
Extreme 0.003
0.01
1 year
0.00
Extreme 0.003
0.01
3 years
0.00
Extreme 0.003
0.02
5 years
0.00
Extreme 0.002
0.05
10 years
0.00
Extreme 0.002
0.11
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01-12-31
Director of Finance/CFO 51 18-12-27
Chief Operating Officer - 00-12-31
Members of the board TitleAgeSince
Director/Board Member - 15-01-13
Director/Board Member 60 20-01-12
Chairman - 15-04-12
More insiders
Date Price Change Volume
24-04-30 0.004 0.00% 3 147 162
24-04-29 0.004 0.00% 55,888,860
24-04-26 0.004 0.00% 328,140
24-04-24 0.004 -20.00% 3,223,219
24-04-23 0.005 +25.00% 2,406,841

Delayed Quote Australian S.E., April 30, 2024 at 02:10 am

More quotes
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Calendar
More about the company